The company plans to use the newly secured funding to expand the indications of its Grabody platform into high-unmet-need areas
Masitinib targets mast cells, which play a critical role in severe forms of SCD and its complications, including vaso-occlusive crises, acute chest syndrome, and pain
The new single-use commercial facility will be among India’s largest, featuring advanced technologies to produce high-quality biologics and specialty pharmaceuticals
The portfolio includes foundational patents on the production, composition, and commercial use of NR
Production at Biocon Biologics’ own facilities is scheduled to begin once technology transfers and regulatory approvals are finalized
Under the agreement, AVT06 is licensed to enter the US market in the fourth quarter of 2026
This recognition demonstrate excellence in intellectual property (IP) value creation.
Hansoh Pharma will receive an upfront payment in the low double-digit millions
Qfitlia is the first antithrombin (AT)-lowering therapy approved for routine prophylaxis in hemophilia
Subscribe To Our Newsletter & Stay Updated
